Elevation Oncology Inc
NASDAQ:ELEV
Elevation Oncology Inc
NASDAQ:ELEV
Price:
0.365
USD
-2.12%
Market Closed
Market Cap:
$21.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Elevation Oncology Inc
NASDAQ:ELEV
|
US |
|
Simonds Group Ltd
ASX:SIO
|
AU |
|
W
|
Wonderfi Technologies Inc
OTC:WONDF
|
CA |
|
K
|
Krungthai Card PCL
SET:KTC
|
TH |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
US |
|
S
|
Square Enix Holdings Co Ltd
TSE:9684
|
JP |
|
Rubrik Inc
NYSE:RBRK
|
US |
|
Skandinaviska Enskilda Banken AB
STO:SEB A
|
SE |
|
L
|
LAI YIH Footware Co Ltd
TWSE:6890
|
KY |
|
H
|
Huddlestock Fintech AS
OSE:HUDL
|
NO |
Cash Flow Statement
Cash Flow Statement
Elevation Oncology Inc
Elevation Oncology Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(17)
|
(20)
|
(22)
|
(31)
|
(32)
|
(44)
|
(59)
|
(86)
|
(95)
|
(95)
|
(85)
|
(57)
|
(46)
|
(39)
|
(40)
|
(42)
|
(44)
|
(48)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
4
|
4
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
4
|
3
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
3
|
|
| Change in Working Capital |
5
|
0
|
0
|
6
|
0
|
7
|
16
|
6
|
6
|
2
|
(12)
|
(9)
|
(14)
|
(13)
|
(7)
|
0
|
4
|
5
|
|
| Cash from Operating Activities |
(12)
N/A
|
(20)
-64%
|
(21)
-6%
|
(25)
-15%
|
(30)
-22%
|
(35)
-15%
|
(40)
-16%
|
(77)
-90%
|
(85)
-12%
|
(88)
-3%
|
(93)
-5%
|
(62)
+33%
|
(56)
+9%
|
(49)
+13%
|
(43)
+11%
|
(38)
+11%
|
(36)
+5%
|
(40)
-9%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(79)
|
(69)
|
(55)
|
(44)
|
62
|
68
|
16
|
12
|
6
|
(49)
|
(13)
|
(8)
|
(5)
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(79)
N/A
|
(69)
+13%
|
(56)
+19%
|
(44)
+20%
|
61
N/A
|
68
+10%
|
16
-76%
|
12
-29%
|
6
-51%
|
(49)
N/A
|
(13)
+73%
|
(8)
+37%
|
(5)
+37%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
90
|
0
|
157
|
162
|
97
|
97
|
5
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
32
|
45
|
45
|
45
|
15
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
30
|
30
|
77
|
47
|
47
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
90
N/A
|
65
-28%
|
157
+142%
|
162
+3%
|
97
-40%
|
97
+0%
|
5
-95%
|
30
+482%
|
30
0%
|
30
+1%
|
77
+161%
|
48
-38%
|
48
+0%
|
78
+63%
|
45
-42%
|
45
0%
|
45
+0%
|
15
-67%
|
|
| Change in Cash | |||||||||||||||||||
| Net Change in Cash |
78
N/A
|
45
-43%
|
135
+203%
|
137
+1%
|
67
-51%
|
(17)
N/A
|
(104)
-516%
|
(103)
+1%
|
(100)
+2%
|
3
N/A
|
52
+1 715%
|
2
-96%
|
3
+46%
|
35
+940%
|
(47)
N/A
|
(7)
+86%
|
0
N/A
|
(30)
N/A
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(12)
N/A
|
(20)
-63%
|
(21)
-6%
|
(25)
-15%
|
(30)
-22%
|
(35)
-15%
|
(40)
-16%
|
(77)
-90%
|
(86)
-12%
|
(88)
-3%
|
(93)
-5%
|
(62)
+33%
|
(56)
+9%
|
(49)
+13%
|
(43)
+11%
|
(38)
+11%
|
(36)
+5%
|
(40)
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
